arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

argenx SE

ARGX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$867.94
Today
as of Aug 5, 16:45 ET
Last 30 days -4.88% Jun 29 → Aug 05
$822.08 $853.66 $885.23 $916.81 $948.39 Jun 29 Jul 07 Jul 14 Jul 22 Jul 29 Aug 05
Open
$846.75
High
$896.60
Low
$845.88
Volume
$794,466
Avg Vol
$363,893
Mkt Cap
$54.2B
P/E (TTM)
—
Beta
—
52w High
$934.62
52w Low
$510.06
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 2 ● 23 ▼ 0
Aug 4 · 16:00 Zacks neutral
What Makes Argenx (ARGX) a New Buy Stock
Aug 4 · 15:35 Insider Monkey neutral
Argenx SE (ARGX) Prepares to Demonstrate Vyvgart’s Efficacy in Broader Autoimmune Diseases
Aug 4 · 03:01 Morningstar Research neutral
Analyst Report: argenx SE
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$510
$935
84% of range
Avg surprise (last 3)
+16.6%
Avg reaction (last 2)
-5.6%
0% positive
Latest IV / EM
38%
EM ±6.4% · $870 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$2.32$3.12$3.92$4.72$5.52 Actual $2.58Est $2.32Actual $3.74Est $2.84Actual $5.52Est $5.16 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $5.52 $5.16 +7.0% +114.0% -2.5% earnings
Thu Jul 31, 2025Jun/2025 $3.74 $2.84 +31.7% — — earnings
Thu May 8, 2025Mar/2025 $2.58 $2.32 +11.2% — -8.6% earnings

Implied volatility — last 90 days

32%37%42%47%52% Jun 07 — IV 40% · EM ±5.6%Jun 08 — IV 39% · EM ±5.2%Jun 09 — IV 40% · EM ±5.0%Jun 10 — IV 39% · EM ±4.6%Jun 11 — IV 34% · EM ±3.8%Jun 12 — IV 35% · EM ±3.5%Jun 15 — IV 38% · EM ±2.7%Jun 16 — IV 40% · EM ±2.3%Jun 17 — IV 41% · EM ±1.7%Jun 19 — IV 35% · EM ±7.7%Jun 22 — IV 35% · EM ±7.3%Jun 23 — IV 37% · EM ±7.6%Jun 24 — IV 36% · EM ±7.2%Jun 25 — IV 35% · EM ±6.8%Jun 26 — IV 34% · EM ±6.4%Jun 29 — IV 34% · EM ±6.0%Jun 30 — IV 34% · EM ±5.9%Jul 01 — IV 33% · EM ±5.5%Jul 02 — IV 34% · EM ±5.5%Jul 03 — IV 35% · EM ±5.5%Jul 06 — IV 36% · EM ±5.0%Jul 07 — IV 37% · EM ±4.9%Jul 08 — IV 37% · EM ±4.7%Jul 09 — IV 36% · EM ±4.3%Jul 10 — IV 36% · EM ±3.9%Jul 13 — IV 43% · EM ±3.6%Jul 14 — IV 42% · EM ±3.1%Jul 15 — IV 44% · EM ±2.6%Jul 16 — IV 53% · EM ±2.2%Jul 20 — IV 40% · EM ±9.6%Jul 21 — IV 40% · EM ±9.3%Jul 22 — IV 41% · EM ±9.3%Jul 23 — IV 37% · EM ±8.3%Jul 24 — IV 36% · EM ±7.9%Jul 27 — IV 38% · EM ±7.8%Jul 28 — IV 37% · EM ±7.6%Jul 29 — IV 38% · EM ±7.6%Jul 30 — IV 37% · EM ±7.3%Jul 31 — IV 37% · EM ±7.1%Aug 03 — IV 39% · EM ±6.8%Aug 04 — IV 40% · EM ±6.9%Aug 05 — IV 38% · EM ±6.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in